Application of nanodiagnostics and nanotherapy to CNS diseases

Weiyuan Zhang, Wenyue Wang, David X Yu, Zhicheng Xiao, Zhiyong He

Research output: Contribution to journalReview ArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Alzheimer's disease, Parkinson's disease and stroke are the most common CNS diseases, all characterized by progressive cellular dysfunction and death in specific areas of the nervous system. Therapeutic development for these diseases has lagged behind other disease areas due to difficulties in early diagnosis, long disease courses and drug delivery challenges, not least due to the blood-brain barrier. Over recent decades, nanotechnology has been explored as a potential tool for the diagnosis, treatment and monitoring of CNS diseases. In this review, we describe the application of nanotechnology to common CNS diseases, highlighting disease pathogenesis and the underlying mechanisms and promising functional outcomes that make nanomaterials ideal candidates for early diagnosis and therapy. Moreover, we discuss the limitations of nanotechnology, and possible solutions.

Original languageEnglish
Pages (from-to)2341-2371
Number of pages31
JournalNanomedicine
Volume13
Issue number18
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • blood-brain barrier
  • nanotechnology
  • neurodegenerative disease
  • neuroinflammation
  • theranostics

Cite this

Zhang, Weiyuan ; Wang, Wenyue ; Yu, David X ; Xiao, Zhicheng ; He, Zhiyong. / Application of nanodiagnostics and nanotherapy to CNS diseases. In: Nanomedicine. 2018 ; Vol. 13, No. 18. pp. 2341-2371.
@article{ed9739e25d9d49a68f9a1243df63d0bc,
title = "Application of nanodiagnostics and nanotherapy to CNS diseases",
abstract = "Alzheimer's disease, Parkinson's disease and stroke are the most common CNS diseases, all characterized by progressive cellular dysfunction and death in specific areas of the nervous system. Therapeutic development for these diseases has lagged behind other disease areas due to difficulties in early diagnosis, long disease courses and drug delivery challenges, not least due to the blood-brain barrier. Over recent decades, nanotechnology has been explored as a potential tool for the diagnosis, treatment and monitoring of CNS diseases. In this review, we describe the application of nanotechnology to common CNS diseases, highlighting disease pathogenesis and the underlying mechanisms and promising functional outcomes that make nanomaterials ideal candidates for early diagnosis and therapy. Moreover, we discuss the limitations of nanotechnology, and possible solutions.",
keywords = "blood-brain barrier, nanotechnology, neurodegenerative disease, neuroinflammation, theranostics",
author = "Weiyuan Zhang and Wenyue Wang and Yu, {David X} and Zhicheng Xiao and Zhiyong He",
year = "2018",
month = "9",
day = "1",
doi = "10.2217/nnm-2018-0163",
language = "English",
volume = "13",
pages = "2341--2371",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine",
number = "18",

}

Application of nanodiagnostics and nanotherapy to CNS diseases. / Zhang, Weiyuan; Wang, Wenyue; Yu, David X; Xiao, Zhicheng; He, Zhiyong.

In: Nanomedicine, Vol. 13, No. 18, 01.09.2018, p. 2341-2371.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Application of nanodiagnostics and nanotherapy to CNS diseases

AU - Zhang, Weiyuan

AU - Wang, Wenyue

AU - Yu, David X

AU - Xiao, Zhicheng

AU - He, Zhiyong

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Alzheimer's disease, Parkinson's disease and stroke are the most common CNS diseases, all characterized by progressive cellular dysfunction and death in specific areas of the nervous system. Therapeutic development for these diseases has lagged behind other disease areas due to difficulties in early diagnosis, long disease courses and drug delivery challenges, not least due to the blood-brain barrier. Over recent decades, nanotechnology has been explored as a potential tool for the diagnosis, treatment and monitoring of CNS diseases. In this review, we describe the application of nanotechnology to common CNS diseases, highlighting disease pathogenesis and the underlying mechanisms and promising functional outcomes that make nanomaterials ideal candidates for early diagnosis and therapy. Moreover, we discuss the limitations of nanotechnology, and possible solutions.

AB - Alzheimer's disease, Parkinson's disease and stroke are the most common CNS diseases, all characterized by progressive cellular dysfunction and death in specific areas of the nervous system. Therapeutic development for these diseases has lagged behind other disease areas due to difficulties in early diagnosis, long disease courses and drug delivery challenges, not least due to the blood-brain barrier. Over recent decades, nanotechnology has been explored as a potential tool for the diagnosis, treatment and monitoring of CNS diseases. In this review, we describe the application of nanotechnology to common CNS diseases, highlighting disease pathogenesis and the underlying mechanisms and promising functional outcomes that make nanomaterials ideal candidates for early diagnosis and therapy. Moreover, we discuss the limitations of nanotechnology, and possible solutions.

KW - blood-brain barrier

KW - nanotechnology

KW - neurodegenerative disease

KW - neuroinflammation

KW - theranostics

UR - http://www.scopus.com/inward/record.url?scp=85054890817&partnerID=8YFLogxK

U2 - 10.2217/nnm-2018-0163

DO - 10.2217/nnm-2018-0163

M3 - Review Article

VL - 13

SP - 2341

EP - 2371

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 18

ER -